Gaming of U.S. Patent System Is Keeping Drug Prices Sky High
Save America’s Patent System
Addressing Drug Patent Abuse: Restoring The Role Of Inter Partes Review
An Entrepreneur’s Quest To Fix Drug Patents And Save Lives
Ford School hosts conversation on drug patent system reform
Ten years ago, I testified before Congress about drug pricing — and it’s only gotten worse. Here’s what’s wrong, and how we may be able to fix it.
Senate Targets Hoarding of Drug Patents to Deter Competition
Report Finds 89% of Total U.S. Patent Applications on Humira Were Filed After FDA Approval – Pointing to a Deliberate Strategy to Delay Competition
I-MAK Welcomes Two New Board Members to Champion the Access to Medicines Movement
California Says AbbVie Paid $1.2B In Kickbacks To Humira Ambassadors